{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:45:51Z","timestamp":1791747951464,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NIH K01MH127309"],"award-info":[{"award-number":["NIH K01MH127309"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["NIH R01MD018977"],"award-info":[{"award-number":["NIH R01MD018977"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clim.2026.110779","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:18:34Z","timestamp":1790378314000},"page":"110779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus"],"prefix":"10.1016","volume":"288","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3539-5351","authenticated-orcid":false,"given":"David S.","family":"Pisetsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Engelhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Eudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Vezza","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Clowse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Criscione-Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithu","family":"Maheswaranathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sadun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2026.110779_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"10.1016\/j.clim.2026.110779_bb0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2026.110779_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/acr2.11343","article-title":"Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding HLA-DRB1 genotype associations and immunological and clinical manifestations","volume":"4","author":"Diaz-Gallo","year":"2022","journal-title":"ACR Open Rheumatol."},{"issue":"7","key":"10.1016\/j.clim.2026.110779_bb0020","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard-2022-223808","article-title":"Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes","volume":"82","author":"Choi","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.clim.2026.110779_bb0025","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41590-024-01898-7","article-title":"The immunology of systemic lupus erythematosus","volume":"25","author":"Tsokos","year":"2024","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2026.110779_bb0030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.clim.2026.110779_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350918","article-title":"Canonical and noncanonical functions of complement in systemic lupus erythematosus","volume":"54","author":"Pickering","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2026.110779_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102979","article-title":"The complement system and human autoimmune diseases","volume":"137","author":"Coss","year":"2023","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.clim.2026.110779_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040626","article-title":"Expanding the role of complement therapies: the case for lupus nephritis","volume":"10","author":"Li","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.clim.2026.110779_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"11","key":"10.1016\/j.clim.2026.110779_bb0055","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.4049\/jimmunol.163.11.6306","article-title":"Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus","volume":"163","author":"Vallin","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2026.110779_bb0060","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2026.110779_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000336","article-title":"Type I interferons in host defence and inflammatory diseases","volume":"6","author":"Crow","year":"2019","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.clim.2026.110779_bb0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","article-title":"Anti-DNA antibodies - quintessential biomarkers of SLE","volume":"12","author":"Pisetsky","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2026.110779_bb0075","first-page":"691","article-title":"Independent expression of autoantibodies in systemic lupus erythematosus","volume":"9","author":"McCarty","year":"1982","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2026.110779_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-021-00984-1","article-title":"A review of complement activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"10.1016\/j.clim.2026.110779_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020367","article-title":"Complement as a biomarker for systemic lupus erythematosus","volume":"13","author":"Ayano","year":"2023","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.clim.2026.110779_bb0090","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.43220","article-title":"The dynamics of antinuclear antibody production in systemic lupus erythematosus: new insights for new therapies","volume":"77","author":"Aringer","year":"2025","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2026.110779_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1454747","article-title":"Cutting-edge approaches to B-cell depletion in autoimmune diseases","volume":"15","author":"Robinson","year":"2024","journal-title":"Front. Immunol."},{"issue":"10416","key":"10.1016\/j.clim.2026.110779_bb0100","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","article-title":"CAR T-cell therapy in autoimmune diseases","volume":"402","author":"Schett","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clim.2026.110779_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103719","article-title":"FcRn inhibitors: transformative advances and significant impacts on IgG-mediated autoimmune diseases","volume":"24","author":"Zhu","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"10424","key":"10.1016\/j.clim.2026.110779_bb0110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clim.2026.110779_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1279","article-title":"Autoantibodies against complement component C1q in systemic lupus erythematosus","volume":"10","author":"Trendelenburg","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.clim.2026.110779_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1410032","article-title":"Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review","volume":"15","author":"Calatroni","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2026.110779_bb0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.molimm.2015.05.010","article-title":"C1q, antibodies and anti-C1q autoantibodies","volume":"68","author":"Beurskens","year":"2015","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2026.110779_bb0130","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clim.2026.110779_bb0135","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.clim.2026.110779_bb0140","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2026.110779_bb0145","first-page":"53","article-title":"Validity and reliability of lupus activity measures in the routine clinic setting","volume":"19","author":"Petri","year":"1992","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2026.110779_bb0150","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2026.110779_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2018.05.014","article-title":"The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination","volume":"459","author":"Mummert","year":"2018","journal-title":"J. Immunol. Methods"},{"issue":"11","key":"10.1016\/j.clim.2026.110779_bb0160","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/art.42941","article-title":"Association of autoantibody concentrations and trajectories with lupus nephritis histologic features and treatment response","volume":"76","author":"Fava","year":"2024","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.clim.2026.110779_bb0165","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.clim.2026.110779_bb0170","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0961203311434938","article-title":"Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE","volume":"21","author":"Ahlin","year":"2012","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.clim.2026.110779_bb0175","first-page":"1495","article-title":"Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus","volume":"30","author":"Mannik","year":"2003","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2026.110779_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78213-5","article-title":"Accumulation of antinuclear associated antibodies in circulating immune complexes is more prominent in SLE patients from Sudan than Sweden","volume":"10","author":"Elbagir","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.clim.2026.110779_bb0185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.semarthrit.2020.06.009","article-title":"The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort","volume":"50","author":"Durcan","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2026.110779_bb0190","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2021-221662","article-title":"Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE","volume":"81","author":"Hubbard","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.clim.2026.110779_bb0195","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.1780290607","article-title":"Complement-activating abilities of defined antinuclear antibodies","volume":"29","author":"Kanayama","year":"1986","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.clim.2026.110779_bb0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1191\/0961203304lu1007oa","article-title":"Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus","volume":"13","author":"Rubin","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2026.110779_bb0205","article-title":"Epitope-specific anti-C1q autoantibodies in systemic lupus erythematosus","volume":"12","author":"Kleer","year":"2021","journal-title":"Front. Immunol."},{"issue":"50","key":"10.1016\/j.clim.2026.110779_bb0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2310666120","article-title":"Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation","volume":"120","author":"Dijkstra","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.clim.2026.110779_bb0215","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1172\/JCI113684","article-title":"Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q","volume":"82","author":"Uwatoko","year":"1988","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.clim.2026.110779_bb0220","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.158.10.4525","article-title":"C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited","volume":"158","author":"Korb","year":"1997","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2026.110779_bb0225","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","article-title":"Direct binding of C1q to apoptotic cells and cell blebs induces complement activation","volume":"32","author":"Nauta","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2026.110779_bb0230","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-025-03536-5","article-title":"Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis","volume":"27","author":"Calatroni","year":"2025","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.clim.2026.110779_bb0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02918613","article-title":"IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus","volume":"11","author":"Siegert","year":"1992","journal-title":"Immunol. Res."},{"issue":"12","key":"10.1016\/j.clim.2026.110779_bb0240","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.imbio.2014.07.004","article-title":"Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro","volume":"219","author":"Pang","year":"2014","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.clim.2026.110779_bb0245","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clim.2015.06.014","article-title":"Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways","volume":"160","author":"Thanei","year":"2015","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2026.110779_bb0250","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1172\/JCI200421075","article-title":"Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes","volume":"114","author":"Trouw","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.clim.2026.110779_bb0255","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI200422820","article-title":"Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus","volume":"114","author":"Holers","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2026.110779_bb0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2013.06.002","article-title":"Anti-DNA antibodies cross-react with C1q","volume":"44","author":"Franchin","year":"2013","journal-title":"J. Autoimmun."},{"issue":"6176","key":"10.1016\/j.clim.2026.110779_bb0265","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.clim.2026.110779_bb0270","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/ndt\/gfae178","article-title":"Anti-C1Q monitoring predicts relapses of lupus nephritis","volume":"39","author":"Calatroni","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.clim.2026.110779_bb0275","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00296-011-1962-3","article-title":"Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4","volume":"32","author":"Julkunen","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.clim.2026.110779_bb0280","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004879","article-title":"Tree-based analysis","volume":"12","author":"Banerjee","year":"2019","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"11","key":"10.1016\/j.clim.2026.110779_bb0285","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2014-02-555169","article-title":"A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow","volume":"125","author":"Mei","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clim.2026.110779_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.08.023","article-title":"Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy","volume":"31","author":"Nunez","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.clim.2026.110779_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-026-01779-6","article-title":"BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial","volume":"19","author":"Hong","year":"2026","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.clim.2026.110779_bb0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/joim.70146","article-title":"Advances in the treatment of systemic lupus erythematosus: biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic","volume":"300","author":"van Vollenhoven","year":"2026","journal-title":"J. Intern. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:49:04Z","timestamp":1791744544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":60,"alternative-id":["S1521661626001178"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110779","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110779"}}